Ellem KA - Search Results

1

Gene transfer to dendritic cells induced a protective immunity against melanoma.

Metharom P, Ellem KA, Wei MQ. Metharom P, et al. Among authors: ellem ka. Cell Mol Immunol. 2005 Aug;2(4):281-8. Cell Mol Immunol. 2005. PMID: 16274626 Free article.

2

Search for "weapons of mass destruction" for cancer -- immuno/ gene therapy comes of age.

Wei MQ, Metharom P, Ellem KA, Barth S. Wei MQ, et al. Among authors: ellem ka. Cell Mol Immunol. 2005 Oct;2(5):351-7. Cell Mol Immunol. 2005. PMID: 16368061 Free article. Review.

3

Lentiviral vector-mediated tyrosinase-related protein 2 gene transfer to dendritic cells for the therapy of melanoma.

Metharom P, Ellem KA, Schmidt C, Wei MQ. Metharom P, et al. Among authors: ellem ka. Hum Gene Ther. 2001 Dec 10;12(18):2203-13. doi: 10.1089/10430340152710540. Hum Gene Ther. 2001. PMID: 11779404

4

The significance of controlled conditions in lentiviral vector titration and in the use of multiplicity of infection (MOI) for predicting gene transfer events.

Zhang B, Metharom P, Jullie H, Ellem KA, Cleghorn G, West MJ, Wei MQ. Zhang B, et al. Among authors: ellem ka. Genet Vaccines Ther. 2004 Aug 4;2(1):6. doi: 10.1186/1479-0556-2-6. Genet Vaccines Ther. 2004. PMID: 15291957 Free PMC article.

5

Novel bovine lentiviral vectors based on Jembrana disease virus.

Metharom P, Takyar S, Xia HH, Ellem KA, Macmillan J, Shepherd RW, Wilcox GE, Wei MQ. Metharom P, et al. Among authors: ellem ka. J Gene Med. 2000 May-Jun;2(3):176-85. doi: 10.1002/(SICI)1521-2254(200005/06)2:3<176::AID-JGM106>3.0.CO;2-Q. J Gene Med. 2000. PMID: 10894263

6

Development of disabled, replication-defective gene transfer vectors from the Jembrana disease virus, a new infectious agent of cattle.

Metharom P, Takyar S, Xia HQ, Ellem KA, Wilcox GE, Wei MQ. Metharom P, et al. Among authors: ellem ka. Vet Microbiol. 2001 May 3;80(1):9-22. doi: 10.1016/s0378-1135(00)00376-x. Vet Microbiol. 2001. PMID: 11278119

7

Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumours.

Wei MQ, Ellem KA, Dunn P, West MJ, Bai CX, Vogelstein B. Wei MQ, et al. Among authors: ellem ka. Eur J Cancer. 2007 Feb;43(3):490-6. doi: 10.1016/j.ejca.2006.10.005. Epub 2006 Nov 17. Eur J Cancer. 2007. PMID: 17113280 Review.

8

VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death.

Liu CS, Kong B, Xia HH, Ellem KA, Wei MQ. Liu CS, et al. Among authors: ellem ka. J Gene Med. 2001 Mar-Apr;3(2):145-52. doi: 10.1002/jgm.164. J Gene Med. 2001. PMID: 11318113

9

Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma.

Marshall JA, Forster TH, Purdie DM, Lanagan CM, O'Connor LE, O'Rourke MG, Johnson MK, See JL, Ellem KA, Martinez NR, López JA, Schmidt CW. Marshall JA, et al. Among authors: ellem ka. Immunol Cell Biol. 2006 Jun;84(3):295-302. doi: 10.1111/j.1440-1711.2006.01445.x. Immunol Cell Biol. 2006. PMID: 16681827

10

Dendritic cell immunotherapy for stage IV melanoma.

O'Rourke MG, Johnson MK, Lanagan CM, See JL, O'Connor LE, Slater GJ, Thomas D, Lopez JA, Martinez NR, Ellem KA, Schmidt CW. O'Rourke MG, et al. Among authors: ellem ka. Melanoma Res. 2007 Oct;17(5):316-22. doi: 10.1097/CMR.0b013e3282c3a73b. Melanoma Res. 2007. PMID: 17885587 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters